Telesis Bio, Inc. expects to report revenue for the fourth quarter of 2022 of $9 million compared to $3 million for the same period in 2021 representing growth of more than 190% for the same period.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.45 USD | -4.96% |
|
-30.86% | -51.96% |
05-09 | Earnings Flash (TBIO) TELESIS BIO Reports Q1 Revenue $3.4M | MT |
05-09 | Telesis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.96% | 5.81M | |
+6.37% | 216B | |
+10.21% | 189B | |
+28.22% | 153B | |
+34.42% | 114B | |
+1.18% | 63.2B | |
+19.21% | 54.78B | |
+0.13% | 48.47B | |
-4.16% | 38.88B | |
+2.39% | 36.14B |
- Stock Market
- Equities
- TBIO Stock
- News Telesis Bio, Inc.
- Telesis Bio Provides Revenue Guidance for the Fourth Quarter of 2022